36th international symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 March 2016 RM Bateman, MD Sharpe, JE Jagger, CG Ellis, J Solé-Violán, ... Critical care 20, 13-182, 2016 | 154 | 2016 |
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle S Eliasof, D Lazarus, CG Peters, RI Case, RO Cole, J Hwang, T Schluep, ... Proceedings of the National Academy of Sciences 110 (37), 15127-15132, 2013 | 151 | 2013 |
Granule exocytosis is required for platelet spreading: differential sorting of α-granules expressing VAMP-7 CG Peters, AD Michelson, R Flaumenhaft Blood, The Journal of the American Society of Hematology 120 (1), 199-206, 2012 | 113 | 2012 |
Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar O Aisiku, CG Peters, K De Ceunynck, CC Ghosh, JR Dilks, ... Blood, The Journal of the American Society of Hematology 125 (12), 1976-1985, 2015 | 95 | 2015 |
Translational impact of nanoparticle–drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer E Pham, MJ Birrer, S Eliasof, EG Garmey, D Lazarus, CR Lee, S Man, ... Clinical Cancer Research 21 (4), 808-818, 2015 | 87 | 2015 |
The platelet actin cytoskeleton associates with SNAREs and participates in α-granule secretion K Woronowicz, JR Dilks, N Rozenvayn, L Dowal, PS Blair, CG Peters, ... Biochemistry 49 (21), 4533-4542, 2010 | 86 | 2010 |
PAR1 agonists stimulate APC-like endothelial cytoprotection and confer resistance to thromboinflammatory injury K De Ceunynck, CG Peters, A Jain, SJ Higgins, O Aisiku, JL Fitch-Tewfik, ... Proceedings of the National Academy of Sciences 115 (5), E982-E991, 2018 | 72 | 2018 |
VAMP-7 links granule exocytosis to actin reorganization during platelet activation S Koseoglu, CG Peters, JL Fitch-Tewfik, O Aisiku, L Danglot, T Galli, ... Blood, The Journal of the American Society of Hematology 126 (5), 651-660, 2015 | 71 | 2015 |
CRLX101, a nanoparticle–drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF1α X Tian, M Nguyen, HP Foote, JM Caster, KC Roche, CG Peters, P Wu, ... Cancer research 77 (1), 112-122, 2017 | 67 | 2017 |
CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of … SJ Conley, TL Baker, JP Burnett, RL Theisen, D Lazarus, CG Peters, ... Breast cancer research and treatment 150, 559-567, 2015 | 63 | 2015 |
Megakaryocytes package contents into separate α-granules that are differentially distributed in platelets EM Battinelli, JN Thon, R Okazaki, CG Peters, P Vijey, AR Wilkie, ... Blood Advances 3 (20), 3092-3098, 2019 | 60 | 2019 |
Preclinical efficacy of bevacizumab with CRLX101, an investigational nanoparticle–drug conjugate, in treatment of metastatic triple-negative breast cancer E Pham, M Yin, CG Peters, CR Lee, D Brown, P Xu, S Man, L Jayaraman, ... Cancer research 76 (15), 4493-4503, 2016 | 59 | 2016 |
Dynamin-related protein-1 controls fusion pore dynamics during platelet granule exocytosis S Koseoglu, JR Dilks, CG Peters, JL Fitch-Tewfik, NA Fadel, R Jasuja, ... Arteriosclerosis, thrombosis, and vascular biology 33 (3), 481-488, 2013 | 44 | 2013 |
Identification, localization and interaction of SNARE proteins in atrial cardiac myocytes CG Peters, DF Miller, DR Giovannucci Journal of molecular and cellular cardiology 40 (3), 361-374, 2006 | 42 | 2006 |
Visualizing form and function in organotypic slices of the adult mouse parotid gland JD Warner, CG Peters, R Saunders, JH Won, MJ Betzenhauser, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 295 (3 …, 2008 | 31 | 2008 |
Tumor selective silencing using an RNAi-conjugated polymeric nanopharmaceutical S Svenson, RI Case, RO Cole, J Hwang, SR Kabir, D Lazarus, P Lim Soo, ... Molecular Pharmaceutics 13 (3), 737-747, 2016 | 26 | 2016 |
Defining a rat blood pressure quantitative trait locus to a< 81.8 kb congenic segment: comprehensive sequencing and renal transcriptome analysis K Gopalakrishnan, J Saikumar, CG Peters, S Kumarasamy, P Farms, ... Physiological genomics 42 (2), 153-161, 2010 | 22 | 2010 |
Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term … WY Ding, M Proietti, G Boriani, L Fauchier, C Blomström-Lundqvist, ... EP Europace 24 (5), 721-728, 2022 | 14 | 2022 |
The secreted tyrosine kinase VLK is essential for normal platelet activation and thrombus formation L Revollo, G Merrill-Skoloff, K De Ceunynck, JR Dilks, S Guo, MR Bordoli, ... Blood, The Journal of the American Society of Hematology 139 (1), 104-117, 2022 | 10 | 2022 |
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general … VL Malavasi, M Vitolo, M Proietti, I Diemberger, L Fauchier, F Marin, ... European journal of clinical investigation 52 (7), e13773, 2022 | 9 | 2022 |